Utama › Kanser Hati (Karsinoma Hepatoselular) › Maryland › Baltimore
Kajian klinikal Kanser Hati (Karsinoma Hepatoselular) di Baltimore, MD
11 kajian untuk Kanser Hati (Karsinoma Hepatoselular) sedang mencari peserta di lokasi dalam dan sekitar Baltimore (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #14, Baltimore
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Mengambil pesertaFasa 1/2
- Research Facility, Baltimore
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Mengambil pesertaFasa 1
- John Hopkins University, Baltimore
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Mengambil pesertaKajian pemerhatian
- Johns Hopkins Hospital, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Mengambil pesertaFasa 1/2
- Research Site, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- The John Hopkins Hospital, Baltimore
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Mengambil peserta
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Mengambil pesertaFasa 1/2
- The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Mengambil pesertaFasa 2
- University of Maryland Medical Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi jauh
Kajian Kanser Hati (Karsinoma Hepatoselular) di bandar lain
- Houston, TX31 kajian
- New York City, NY24 kajian
- Dallas, TX19 kajian
- Los Angeles, CA19 kajian
- Boston, MA18 kajian
- Cleveland, OH18 kajian
- Chicago, IL16 kajian
- Philadelphia, PA16 kajian
- Pittsburgh, PA15 kajian
- San Francisco, CA14 kajian
- Orange, CA14 kajian
- Jacksonville, FL14 kajian
Kajian lain di Baltimore
- Kanser Paru-paru Bukan Sel Kecil60 kajian
- Kanser Payudara47 kajian
- Kanser Prostat43 kajian
- Kanser Paru-paru40 kajian
- Kanser (semua jenis)37 kajian
- Kanser Pankreas31 kajian
- Kanser Kolorektal31 kajian
- Kanser Metastatik28 kajian
- Obesiti26 kajian
- Kanser Pundi Kencing24 kajian
- Kegagalan Jantung24 kajian
- Kanser Ovari22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.